Allison Nahin

Allison Nahin has a diverse work experience spanning various roles and industries. Allison currently works as a Business Development Consultant at CEREBRIU since January 2023. Prior to this, they were a Business Development Manager at The Conjugate Group from August 2021 to January 2023.

Earlier in their career, Allison worked as a Scientific Associate II at Novartis Institutes for BioMedical Research (NIBR) from June 2017 to August 2021. Their responsibilities included protein and nucleic acid purification, formulation development, and nanoparticle delivery for in-vivo testing. Allison also conducted experiments, prepared reports, and stayed up-to-date with scientific literature.

Before joining NIBR, Allison served as the Director of Business Development at JournalStat from November 2019 to February 2021. Allison also worked as a Research Associate III at the Broad Institute of MIT and Harvard from March 2016 to June 2017, focusing on protein purification, expression, and biophysical characterization.

Additionally, Allison has held research positions at Scholar Rock and Momenta Pharmaceuticals. Allison gained experience in protein biochemistry and research associate roles during these contract positions.

Furthermore, Allison started their career as a Process Development Associate at Synageva BioPharma Corp. from May 2013 to March 2015. Their work involved enzyme purification, process development, and assay performance.

Overall, Allison Nahin has a strong background in business development, scientific research, and laboratory operations.

Allison Nahin is currently pursuing a degree at Harvard Extension School, with an expected completion date in 2024. Allison previously attended the University of New Hampshire from 2007 to 2012, where they obtained a Bachelor of Science in Biochemistry.